Mechanism on Inhibiting SMMC-7721 Hepatoma Carcinoma Cell Proliferation by Specific Sirna Targeting Human Telomerase Reverse Transcriptase

LI Hai-xia,HAN Jing-jing,ZHANG Yun,ZHANG Zhen-zhong
DOI: https://doi.org/10.3969/j.issn.1001-1978.2011.05.004
2011-01-01
Abstract:Aim To design and identify potent siRNA sequences against hTERT in hepatoma carcinoma cells,and to test influences of the most potent siRNA on hTERT protein expression and cell apoptosis in vitro.Methods Six hTERT-specific siRNA duplexes were designed and synthesized,and transfected into Hepatoma SMMC-7721 cells with LipofectaminTM2 000.In order to identify the most potent sequences against hTERT,sulforhodamine B and RT-PCR methods were adopted to determine cell proliferation and hTERT mRNA level,respectively.Furthermore,cell apoptosis induced by the potent sequences was detected with Annexin V-FITC/PI assay by flow cytometry,and the protein expression level of hTERT was determined by Western blot.Results Two most potent siRNA sequences,siRNA-2 and siRNA-6,were identified based on the SRB and RT-PCR results.In hepatoma cells,both siRNA-2 and siRNA-6 significantly inhibited cell proliferation by 45.3% and 38.2%,respectively,and downregulated hepatoma hTERT mRNA expression by 80% and 75%,respectively.Moreover,either siRNA-2 or siRNA-6 significantly induced cell apoptosis with an apoptotic rate of 20.23% or 17.94%,respectively,and a reduced hTERT protein expression level(P0.05).Conclusion Newly identified siRNA sequences can inhibit the proliferation of hepatoma SMMC-7721 cells,induce cell apoptosis and reduce the expression of hTERT gene,which provides a strong experimental evidence for the gene therapy of liver cancer by targeting hTERT.
What problem does this paper attempt to address?